CD44 and cancer: Aires et al. identified that targeted drug delivery to the CD44 positive cancerous cells can be done by functionalizing the magnetic iron oxide particles with antibodies(anti‐CD44) and gemcitabine derivatives used as anti‐cancer drugs.73 These particles were used as efficient theranostic agents.